Related references
Note: Only part of the references are listed.Bone growth during rapamycin therapy in young rats
Cheryl P. Sanchez et al.
BMC PEDIATRICS (2009)
Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-κB/Sp1-mediated signaling pathways
Mi Hee Park et al.
CARCINOGENESIS (2009)
CXCR4 chemokine receptor antagonists: perspectives in SCLC
Jan A. Burger et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
Daniel Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Prevention and Management of Bone Metastases in Lung Cancer A Review
Hamed Al Husaini et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Monocyte Chemotactic Protein 1 Promotes Lung Cancer-Induced Bone Resorptive Lesions In Vivo
Zhong Cai et al.
NEOPLASIA (2009)
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway
Alexey Pereverzev et al.
BONE (2008)
Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model
Hillary J. Millar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
PLD regulates myoblast differentiation through the mTOR-IGF2 pathway
Mee-Sup Yoon et al.
JOURNAL OF CELL SCIENCE (2008)
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity
Vera Hirsh et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines
Medhi Wangpaichitr et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer
I. Roato et al.
LUNG CANCER (2008)
Akt1 in Osteoblasts and Osteoclasts Controls Bone Remodeling
Naohiro Kawamura et al.
PLOS ONE (2007)
Targeting the protein kinase C family: are we there yet?
Helen J. Mackay et al.
NATURE REVIEWS CANCER (2007)
Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells
Christopher F. MacManus et al.
MOLECULAR CANCER RESEARCH (2007)
Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2
Nicholas Lehman et al.
BLOOD (2006)
Phospholipase D1 regulates phagocyte adhesion
Shankar S. Iyer et al.
JOURNAL OF IMMUNOLOGY (2006)
Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt
JJ Gills et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10
J Kim et al.
CANCER RESEARCH (2006)
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-κB ligand pathway
MS Bendre et al.
CANCER RESEARCH (2005)
Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling
KN Thimmaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A novel protein kinase C α-dependent signal to ERK1/2 activated by αVβ3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells
N Rucci et al.
JOURNAL OF CELL SCIENCE (2005)
Phospholipase D (PLD) gene expression in human neutrophils and HL-60 differentiation
M Di Fulvio et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Implication of phospholipase D2 in oxidant-induced phosphoinositide 3-kinase signaling via Pyk2 activation in PC12 cells
Y Banno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phospholipase D signaling and extracellular signal-regulated kinase-1 and-2 phosphorylation (activation) are required for maximal phorbol ester-induced transglutaminase activity, a marker of keratinocyte differentiation
WB Bollag et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Phospholipase D is involved in myogenic differentiation through remodeling of actin cytoskeleton
H Komati et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Akt1/Akt2 and mammalian target of rapamycin/bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors
T Sugatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Alternative phospholipase D/mTOR survival signal in human breast cancer cells
YH Chen et al.
ONCOGENE (2005)
Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid
Y Kam et al.
FASEB JOURNAL (2004)
The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis
A Durán et al.
DEVELOPMENTAL CELL (2004)
Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells
CR Yang et al.
CELL DEATH AND DIFFERENTIATION (2004)
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53
L Hui et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
YM Zhu et al.
BRITISH JOURNAL OF CANCER (2004)
Participation of protein kinase C β in osteoclast differentiation and function
SW Lee et al.
BONE (2003)
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis
M Orditura et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Share Paper
